Neurotensin modulates the migratory and inflammatory response of macrophages under hyperglycemic conditions

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Moura, Liane I F ^a,b   Silva, Lucília ^a   Leal, Ermelindo C ^a   Tellechea, Ana ^a,c   Cruz, Maria Teresa ^a,c   Carvalho, Eugénia ^a,d  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d The Portuguese Diabetes Association (APDP)   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GLUCOSE; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; NEUROTENSIN; NEUROTENSIN RECEPTOR; CYTOKINE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL FUNCTION; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DIABETIC FOOT; DRUG EFFECT; DRUG MECHANISM; HYPERGLYCEMIA; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; CELL MOTION; IMMUNOLOGY; MACROPHAGE ACTIVATION; MOUSE; DRUG EFFECTS;

ANIMALS; CELL LINE; CELL MOVEMENT; CYTOKINES; HYPERGLYCEMIA; INFLAMMATION; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; NEUROTENSIN;

EID: 84884259661     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/941764     Document Type: Article

References (45)

1. Shaw J. E., Sicree R. A., Zimmet P. Z., Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice 2010 87 1 4 14 2-s2.0-73749083481 10.1016/j.diabres.2009.10.007
2. Brem H., Tomic-Canic M., Cellular and molecular basis of wound healing in diabetes. Journal of Clinical Investigation 2007 117 5 1219 1222 2-s2.0-34248225758 10.1172/JCI32169
3. Lan C.-C. E., Liu I.-H., Fang A.-H., Wen C.-H., Wu C.-S., Hyperglycaemic conditions decrease cultured keratinocyte mobility: implications for impaired wound healing in patients with diabetes. British Journal of Dermatology 2008 159 5 1103 1115 2-s2.0-54249117325 10.1111/j.1365-2133.2008.08789.x
4. Tellechea A., Leal E., Veves A., Carvalho E., Inflammatory and angiogenic abnormalities in diabetic wound healing: role of neuropeptides and therapeutic perspectives. The Open Circulation and Vascular Journal 2010 3 43 55
5. Pradhan L., Nabzdyk C., Andersen N. D., LoGerfo F. W., Veves A., Inflammation and neuropeptides: the connection in diabetic wound healing. Expert Reviews in Molecular Medicine 2009 11 article e2 2-s2.0-63049106661 10.1017/S1462399409000945
6. Kämpfer H., Schmidt R., Geisslinger G., Pfeilschifter J., Frank S., Wound inflammation in diabetic ob/ob mice: functional coupling of prostaglandin biosynthesis to cyclooxygenase-1 activity in diabetes-impaired wound healing. Diabetes 2005 54 5 1543 1551 2-s2.0-17844411514 10.2337/diabetes.54.5.1543
7. Koh T. J., DiPietro L. A., Inflammation and wound healing: the role of the macrophage. Expert Reviews in Molecular Medicine 2011 13 article e23 2-s2.0-80053445847 10.1017/S1462399411001943
8. Bagdade J. D., Root R. K., Bulger R. J., Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 1974 23 1 9 15 2-s2.0-0015984043
9. Alba-Loureiro T. C., Munhoz C. D., Martins J. O., Cerchiaro G. A., Scavone C., Curi R., Sannomiya P., Neutrophil function and metabolism in individuals with diabetes mellitus. Brazilian Journal of Medical and Biological Research 2007 40 8 1037 1044 2-s2.0-34547819727
10. Khanna S., Biswas S., Shang Y., Collard E., Azad A., Kauh C., Bhasker V., Gordillo G. M., Sen C. K., Roy S., Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS ONE 2010 5 3 2-s2.0-77949681013 10.1371/journal.pone.0009539 e9539
11. Martinez F. O., Sica A., Mantovani A., Locati M., Macrophage activation and polarization. Frontiers in Bioscience 2008 13 2 453 461 2-s2.0-38449102676 10.2741/2692
12. de Souza L. F., Jardim F. R., Sauter I. P., de Souza M. M., Bernard E. A., High glucose increases RAW 264.7 macrophages activation by lipoteichoic acid from Staphylococcus aureus. Clinica Chimica Acta 2008 398 1-2 130 133 2-s2.0-54049131622 10.1016/j.cca.2008.09.007
13. Elenkov I. J., Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochemistry International 2008 52 1 40 51 2-s2.0-36849037934 10.1016/j.neuint.2007.06.037
14. Brun P., Mastrotto C., Beggiao E., Stefani A., Barzon L., Sturniolo G. C., Palù G., Castagliuolo I., Neuropeptide neurotensin stimulates intestinal wound healing following chronic intestinal inflammation. American Journal of Physiology 2005 288 4 G621 G629 2-s2.0-15244344525 10.1152/ajpgi.00140.2004
15. Delgado A. V., McManus A. T., Chambers J. P., Exogenous administration of substance P enhances wound healing in a novel skin-injury model. Experimental Biology and Medicine 2005 230 4 271 280 2-s2.0-16444369890
16. Toda M., Suzuki T., Hosono K., Kurihara Y., Kurihara H., Hayashi I., Kitasato H., Hoka S., Majima M., Roles of calcitonin gene-related peptide in facilitation of wound healing and angiogenesis. Biomedicine and Pharmacotherapy 2008 62 6 352 359 2-s2.0-46049086944 10.1016/j.biopha.2008.02.003
17. Pradhan L., Cai X., Wu S., Andersen N. D., Martin M., Malek J., Guthrie P., Veves A., Logerfo F. W., Gene expression of pro-inflammatory cytokines and neuropeptides in diabetic wound healing. Journal of Surgical Research 2011 167 2 336 342 2-s2.0-79954590766 10.1016/j.jss.2009.09.012
18. Jiang M. H., Chung E., Chi G. F., Ahn W., Lim J. E., Hong H. S., Substance P induces M2-type macrophages after spinal cord injury. Neuroreport 2012 23 786 792
19. Lazarus L. H., Brown M. R., Perrin M. H., Distribution, localization and characteristics of neurotensin binding sites in the rat brain. Neuropharmacology 1977 16 9 625 629 2-s2.0-0017715796
20. Zhao D., Zhan Y., Zeng H., Koon H.-W., Moyer M. P., Pothoulakis C., Neurotensin stimulates interleukin-8 expression through modulation of I B α phosphorylation and p65 transcriptional activity: involvement of protein kinase C α Molecular Pharmacology 2005 67 6 2025 2031 2-s2.0-21744453992 10.1124/mol.104.010801
21. Kim H. S., Yumkham S., Choi J. H., Lee S. H., Kim T.-H., Ryu S. H., Suh P.-G., Neurotensin enhances nitric oxide generation via the JAK2-STAT1 pathway in murine macrophage RAW 264.7 cells during costimulation with LPS and IFN γ Neuropeptides 2006 40 3 221 229 2-s2.0-33747719879 10.1016/j.npep.2006. 01.001
22. da Silva L., Neves B. M., Moura L., Cruz M. T., Carvalho E., Neurotensin downregulates the pro-inflammatory properties of skin dendritic cells and increases epidermal growth factor expression. Biochimica et Biophysica Acta 2011 1813 10 1863 1871 2-s2.0-80051782996 10.1016/j.bbamcr.2011.06.018
23. Hartung H.-P., Activation of macrophages by neuropeptides. Brain Behavior and Immunity 1988 2 4 275 281 2-s2.0-0024150543
24. Ganea D., Delgado M., Neuropeptides as modulators of macrophage functions. Regulation of cytokine production and antigen presentation by VIP and PACAP. Archivum Immunologiae et Therapiae Experimentalis 2001 49 2 101 110 2-s2.0-0035222230
25. Vincent J.-P., Mazella J., Kitabgi P., Neurotensin and neurotensin receptors. Trends in Pharmacological Sciences 1999 20 7 302 309 2-s2.0-0001246577 10.1016/S0165-6147(99)01357-7
26. Pfaffl M. W., A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 2001 29 9, article e45 2-s2.0-17344392308
27. Jeon H. K., Jung N. P., Choi I. H., Oh Y. K., Shin H. C., Gwag B. J., Substance P augments nitric oxide production and gene expression in murine macrophages. Immunopharmacology 1999 41 3 219 226 2-s2.0-0032981538 10.1016/S0162-3109(99)00033-8
28. Yaraee R., Ebtekar M., Ahmadiani A., Sabahi F., Neuropeptides (SP and CGRP) augment pro-inflammatory cytokine production in HSV-infected macrophages. International Immunopharmacology 2003 3 13-14 1883 1887 2-s2.0-0242412321 10.1016/S1567-5769(03)00201-7
29. Martin S., Vincent J.-P., Mazella J., Involvement of the neurotensin receptor-3 in the neurotensin-induced migration of human microglia. Journal of Neuroscience 2003 23 4 1198 1205 2-s2.0-0037442515
30. De La Fuente M., Garrido J. J., Arahuetes R. M., Hernanz A., Stimulation of phagocytic function in mouse macrophages by neurotensin and neuromedin N. Journal of Neuroimmunology 1993 42 1 97 104 2-s2.0-0027473055 10.1016/0165-5728(93)90216-L
31. Devaraj S., Venugopal S. K., Singh U., Jialal I., Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase C- α and-β Diabetes 2005 54 1 85 91 2-s2.0-12144255424 10.2337/diabetes.54.1.85
32. Hatanaka E., Monteagudo P. T., Marrocos M. S. M., Campa A., Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes. Clinical and Experimental Immunology 2006 146 3 443 447 2-s2.0-33750846406 10.1111/j.1365-2249.2006.03229.x
33. Dasu M. R., Devaraj S., Zhao L., Hwang D. H., Jialal I., High glucose induces toll-like receptor expression in human monocytes Mechanism of activation. Diabetes 2008 57 11 3090 3098 2-s2.0-58149333718 10.2337/db08-0564
34. Cavaillon J. M., Cytokines and macrophages. Biomedicine and Pharmacotherapy 1994 48 10 445 453 2-s2.0-0028579731 10.1016/0753-3322(94)90005- 1
35. Silswal N., Singh A. K., Aruna B., Mukhopadhyay S., Ghosh S., Ehtesham N. Z., Human resistin stimulates the pro-inflammatory cytokines TNF- α and IL-12 in macrophages by NF- B-dependent pathway. Biochemical and Biophysical Research Communications 2005 334 4 1092 1101 2-s2.0-23044439100 10.1016/j.bbrc.2005.06.202
36. Hill J. R., Kwon G., Marshall C. A., McDaniel M. L., Hyperglycemic levels of glucose inhibit interleukin 1 release from RAW 264.7 murine macrophages by activation of protein kinase C. Journal of Biological Chemistry 1998 273 6 3308 3313 2-s2.0-0032488919 10.1074/jbc.273.6.3308
37. Sia C., Imbalance in Th cell polarization and its relevance in type 1 diabetes mellitus. Review of Diabetic Studies 2005 2 182 186
38. Dicou E., Vincent J.-P., Mazella J., Neurotensin receptor-3/sortilin mediates neurotensin-induced cytokine/chemokine expression in a marine microglial cell line. Journal of Neuroscience Research 2004 78 1 92 99 2-s2.0-4644297206 10.1002/jnr.20231
39. Dvoráková M. C., Pfeil U., Kuncová J., Švíglerová J., Galvis G., Krasteva G., König P., Grau V., Slavíková J., Kummer W., Down-regulation of vasoactive intestinal peptide and altered expression of its receptors in rat diabetic cardiomyopathy. Cell and Tissue Research 2006 323 3 383 393 2-s2.0-32444442070 10.1007/s00441-005-0001-7
40. Hermans E., Maloteaux J.-M., Mechanisms of regulation of neurotensin receptors. Pharmacology and Therapeutics 1998 79 2 89 104 2-s2.0-0031826026 10.1016/S0163-7258(98)00009-6
41. Mazella J., Sortilin/neurotensin receptor-3: a new tool to investigate neurotensin signaling and cellular trafficking? Cellular Signalling 2001 13 1 1 6 2-s2.0-0035109055 10.1016/S0898-6568(00)00130-3
42. Mule F., Serio R., Postorino A., Motility pattern of isolated rat proximal colon and excitatory action of neurotensin. European Journal of Pharmacology 1995 275 2 131 137 2-s2.0-0028960749 10.1016/0014-2999(94)00760-5
43. Hashim S., Li Y., Anand-Srivastava M. B., G protein-linked cell signaling and cardiovascular functions in diabetes/hyperglycemia. Cell Biochemistry and Biophysics 2006 44 1 51 64 2-s2.0-30744460377
44. Akabayashi A., Zaia C. T. B. V., Silva I., Chae H. J., Leibowitz S. F., Neuropeptide Y in the arcuate nucleus is modulated by alterations in glucose utilization. Brain Research 1993 621 2 343 348 2-s2.0-0027169170 10.1016/0006-8993(93)90125-7
45. Matyal R., Mahmood F., Robich M., Glazer H., Khabbaz K., Hess P., Bianchi C., Hagberg R., Hu S.-X., Sellke F. W., Chronic type II diabetes mellitus leads to changes in neuropeptide y receptor expression and distribution in human myocardial tissue. European Journal of Pharmacology 2011 665 1-3 19 28 2-s2.0-79958259260 10.1016/j.ejphar.2011.04.039